文献库，生知库 | 链接生命科学的每一步

日期影响因子

Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial

作者更正：新辅助阿特珠单抗治疗可切除非小细胞肺癌：一项开放标签、单臂 II 期试验

期刊:Nature Medicine

影响因子:50

doi:10.1038/s41591-023-02627-7

Chaft, Jamie E; Oezkan, Filiz; Kris, Mark G; Bunn, Paul A; Wistuba, Ignacio I; Kwiatkowski, David J; Owen, Dwight H; Tang, Yan; Johnson, Bruce E; Lee, Jay M; Lozanski, Gerard; Pietrzak, Maciej; Seweryn, Michal; Byun, Woo Yul; Schulze, Katja; Nicholas, Alan; Johnson, Ann; Grindheim, Jessica; Hilz, Stephanie; Shames, David S; Rivard, Chris; Toloza, Eric; Haura, Eric B; McNamee, Ciaran J; Patterson, G Alexander; Waqar, Saiama N; Rusch, Valerie W; Carbone, David P

细胞生物学

发表日期：2024

文献求助收藏

Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab

接受阿特珠单抗联合贝伐珠单抗治疗后获得持久部分缓解或持久疾病稳定的肝细胞癌患者的临床结果和组织学发现

期刊:Journal of Clinical Oncology

影响因子:41.9

doi:10.1200/JCO.24.00645

Shen, Ying-Chun; Liu, Tsung-Hao; Nicholas, Alan; Soyama, Akihiko; Yuan, Chang-Tsu; Chen, Tse-Ching; Eguchi, Susumu; Yoshizumi, Tomoharu; Itoh, Shinji; Nakamura, Noriaki; Kosaka, Hisashi; Kaibori, Masaki; Ishii, Takamichi; Hatano, Etsuro; Ogawa, Chikara; Naganuma, Atsushi; Kakizaki, Satoru; Cheng, Chih-Hsien; Lin, Po-Ting; Su, Yung-Yeh; Chuang, Chien-Huai; Lu, Li-Chun; Wu, Chi-Jung; Wang, Hung-Wei; Rau, Kun-Ming; Hsu, Chih-Hung; Lin, Shi-Ming; Huang, Yi-Hsiang; Hernandez, Sairy; Finn, Richard S; Kudo, Masatoshi; Cheng, Ann-Lii

细胞生物学

发表日期：2024

文献求助收藏

Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Hepatocellular Carcinoma with Main Trunk and/or Contralateral Portal Vein Invasion in IMbrave150

IMbrave150 研究比较了阿特珠单抗联合贝伐珠单抗与索拉非尼治疗伴有主干和/或对侧门静脉侵犯的肝细胞癌的疗效和安全性

期刊:Liver Cancer

影响因子:9.1

doi:10.1159/000539897

Finn, Richard S; Galle, Peter R; Ducreux, Michel; Cheng, Ann-Lii; Reilly, Norelle; Nicholas, Alan; Hernandez, Sairy; Ma, Ning; Merle, Philippe; Salem, Riad; Li, Daneng; Breder, Valeriy

细胞生物学

发表日期：2024

文献求助收藏

Pertuzumab plus high-dose trastuzumab for HER2-positive breast cancer with brain metastases: PATRICIA final efficacy data

帕妥珠单抗联合高剂量曲妥珠单抗治疗HER2阳性伴脑转移乳腺癌：PATRICIA最终疗效数据

期刊:NPJ Breast Cancer

影响因子:7.6

doi:10.1038/s41523-023-00587-2

Lin, Nancy U; Kumthekar, Priya; Sahebjam, Solmaz; Ibrahim, Nuhad; Fung, Anita; Cheng, Anna; Nicholas, Alan; Sussell, Jesse; Pegram, Mark

发表日期：2023

文献求助收藏

Overall Survival by Response to First-line Induction Treatment with Atezolizumab plus Platinum-based Chemotherapy or Placebo plus Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma

转移性尿路上皮癌一线诱导治疗（阿特珠单抗联合铂类化疗或安慰剂联合铂类化疗）疗效与总生存期的关系

期刊:European Urology Open Science

影响因子:4.5

doi:10.1016/j.euros.2023.10.002

Grande, Enrique; Bamias, Aristotelis; Galsky, Matthew D; Kikuchi, Eiji; Davis, Ian D; Arranz, José Ángel; Rezazadeh Kalebasty, Arash; Garcia Del Muro, Xavier; Park, Se Hoon; De Giorgi, Ugo; Alekseev, Boris; Mencinger, Marina; Izumi, Kouji; Puente, Javier; Li, Jian-Ri; Bernhard, Sandrine; Nicholas, Alan; Telliez, Julie; De Santis, Maria

发表日期：2023

文献求助收藏

Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non-small cell lung cancer

肺癌突变联盟3试验的手术结果：一项II期多中心单臂研究，旨在探讨阿特珠单抗作为新辅助治疗在IB期至IIIB期可切除非小细胞肺癌患者中的疗效和安全性

期刊:Journal of Thoracic and Cardiovascular Surgery

影响因子:4.4

doi:10.1016/j.jtcvs.2022.10.007

Rusch, Valerie W; Nicholas, Alan; Patterson, G Alexander; Waqar, Salama N; Toloza, Eric M; Haura, Eric B; Raz, Dan J; Reckamp, Karen L; Merritt, Robert E; Owen, Dwight H; Finley, David J; McNamee, Ciaran J; Blasberg, Justin D; Garon, Edward B; Mitchell, John D; Doebele, Robert C; Baciewicz, Frank; Nagasaka, Misako; Pass, Harvey I; Schulze, Katja; Johnson, Ann; Bunn, Paul A; Johnson, Bruce E; Kris, Mark G; Kwiatkowski, David J; Wistuba, Ignacio I; Chaft, Jamie E; Carbone, David P; Lee, Jay M

细胞生物学

发表日期：2023

文献求助收藏

Atezolizumab plus Bevacizumab versus Sorafenib for Unresectable Hepatocellular Carcinoma: Results from Older Adults Enrolled in the IMbrave150 Randomized Clinical Trial

阿特珠单抗联合贝伐珠单抗对比索拉非尼治疗不可切除的肝细胞癌：IMbrave150随机临床试验中老年患者的结果

期刊:Liver Cancer

影响因子:9.1

doi:10.1159/000525671

Li, Daneng; Toh, Han Chong; Merle, Philippe; Tsuchiya, Kaoru; Hernandez, Sairy; Verret, Wendy; Nicholas, Alan; Kudo, Masatoshi

细胞生物学

发表日期：2022

文献求助收藏

Pertuzumab Plus High-Dose Trastuzumab in Patients With Progressive Brain Metastases and HER2-Positive Metastatic Breast Cancer: Primary Analysis of a Phase II Study

帕妥珠单抗联合高剂量曲妥珠单抗治疗进展性脑转移和HER2阳性转移性乳腺癌患者：一项II期研究的主要分析

期刊:Journal of Clinical Oncology

影响因子:41.9

doi:10.1200/JCO.20.02822

Lin, Nancy U; Pegram, Mark; Sahebjam, Solmaz; Ibrahim, Nuhad; Fung, Anita; Cheng, Anna; Nicholas, Alan; Kirschbrown, Whitney; Kumthekar, Priya

发表日期：2021

文献求助收藏

Comparative population genomic analyses of transporters within the Asgard archaeal superphylum

阿斯加德古菌超门内转运蛋白的比较群体基因组分析

期刊:PLoS One

影响因子:2.6

doi:10.1371/journal.pone.0247806

Russum, Steven; Lam, Katie Jing Kay; Wong, Nicholas Alan; Iddamsetty, Vasu; Hendargo, Kevin J; Wang, Jianing; Dubey, Aditi; Zhang, Yichi; Medrano-Soto, Arturo; Saier, Milton H Jr

发表日期：2021

文献求助收藏

Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI-Bevacizumab Versus FOLFOX-Bevacizumab for Metastatic Colorectal Cancer (STEAM)

转移性结直肠癌序贯或同步 FOLFOXIRI-贝伐单抗与 FOLFOX-贝伐单抗的 II 期随机试验 (STEAM)

期刊:Oncologist

影响因子:4.2

doi:10.1634/theoncologist.2018-0344

Hurwitz, Herbert I; Tan, Benjamin R; Reeves, James A; Xiong, Henry; Somer, Brad; Lenz, Heinz-Josef; Hochster, Howard S; Scappaticci, Frank; Palma, John F; Price, Richard; Lee, John J; Nicholas, Alan; Sommer, Nicolas; Bendell, Johanna

发表日期：2019

文献求助收藏